CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
|
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Mar. 31, 2012
|
Mar. 31, 2011
|
Mar. 31, 2012
|
Mar. 31, 2011
|
Sep. 30, 2011
|
Sep. 30, 2010
|
|
REVENUES | ||||||
Neurometric information services | $ 25,200 | $ 29,200 | $ 57,200 | $ 56,400 | $ 111,400 | $ 136,100 |
Clinical services | 188,900 | 162,600 | 341,200 | 283,200 | 634,500 | 502,400 |
Sales Revenue, Services, Net | 214,100 | 191,800 | 398,400 | 339,600 | 745,900 | 638,500 |
OPERATING EXPENSES | ||||||
Cost of neurometric services revenues | 35,900 | 36,500 | 75,100 | 72,500 | 147,100 | 135,100 |
Research | 67,400 | 119,300 | 137,100 | 330,300 | 482,800 | 738,800 |
Product development | 162,800 | 116,400 | 275,300 | 260,800 | 442,000 | 381,700 |
Sales and marketing | 315,000 | 347,500 | 645,100 | 594,300 | 1,231,500 | 870,900 |
General and administrative | 1,051,000 | 1,079,200 | 2,112,000 | 2,133,100 | 4,271,900 | 5,017,000 |
Total operating expenses | 1,632,100 | 1,698,900 | 3,244,600 | 3,391,000 | 6,575,300 | 7,143,500 |
OPERATING LOSS | (1,418,000) | (1,507,100) | (2,846,200) | (3,051,400) | (5,829,400) | (6,505,000) |
OTHER INCOME (EXPENSE): | ||||||
Interest income (expense), net | (1,135,700) | (1,329,100) | (2,617,700) | (3,956,100) | (7,567,000) | (360,500) |
Loss on extinguishment of debt | (1,968,000) | (1,094,300) | ||||
Financing fees | (106,200) | (146,700) | (151,500) | (289,300) | (348,600) | (213,400) |
Offering costs | (900) | 0 | (7,700) | 0 | (437,800) | 0 |
Other non-operating income | 458,800 | 0 | ||||
Gain (Loss) on derivative liabilities | (5,733,700) | (3,963,400) | (5,501,700) | 254,200 | 6,826,700 | 0 |
Total other income (expense) | (6,976,500) | (5,439,200) | (8,278,600) | (3,991,200) | (3,035,900) | (1,668,200) |
LOSS BEFORE PROVISION FOR INCOME TAXES | (8,394,500) | (6,946,300) | (11,124,800) | (7,042,600) | (8,865,300) | (8,173,200) |
Income taxes | 0 | 0 | 900 | 1,300 | 1,300 | 800 |
NET LOSS | $ (8,394,500) | $ (6,946,300) | $ (11,125,700) | $ (7,043,900) | $ (8,866,600) | $ (8,174,000) |
NET LOSS PER SHARE: | ||||||
Basic (in dollars per share) | $ (4.48) | $ (3.72) | $ (5.94) | $ (3.77) | $ (4.74) | $ (4.69) |
Diluted (in dollars per share) | $ (4.48) | $ (3.72) | $ (5.94) | $ (3.77) | $ (4.74) | $ (4.69) |
WEIGHTED AVERAGE SHARES OUTSTANDING: | ||||||
Basic (in shares) | 1,873,948 | 1,867,464 | 1,873,766 | 1,867,690 | 1,869,038 | 1,742,570 |
Diluted (in shares) | 1,873,948 | 1,867,464 | 1,873,766 | 1,867,690 | 1,869,038 | 1,742,570 |
X | ||||||||||
- Definition
Aggregate revenue during the period from clinical services rendered in the normal course of business. No definition available.
|
X | ||||||||||
- Definition
Aggregate revenue during the period from neurometric information services rendered in the normal course of business. No definition available.
|
X | ||||||||||
- Definition
The amount of offering costs incurred during the reporting period. No definition available.
|
X | ||||||||||
- Definition
The aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique. No definition available.
|
X | ||||||||||
- Definition
The expense related to research activities incurred by the entity during the reporting period. No definition available.
|
X | ||||||||||
- Definition
Represents the charge against earnings during the period for commitment fees and debt issuance expenses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net Increase or Decrease in the fair value of the derivative or group of derivatives included in earnings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate direct operating costs incurred during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount represents the difference between the fair value of the payments made and the carrying amount of the debt at the time of its extinguishment. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net amount of nonoperating interest income (expense). No definition available.
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|